Welkom bij Campus Sanofi Nederland
- Artikel
- Campus Sanofi
- 19 mrt 2024
Een platform voor beroepsbeoefenaren om betrouwbare en relevante informatie over onze medicijnen en therapieën te vinden.
Lees verderWetenschappelijk nieuws
The RESTORE-G Real World Evidence Study
RESTORE-G: Real-world analysis in insulin-naïve adults with T2D on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†2
Bekijk meer
Advancing the treatment: Meeting the challenge of uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.
Bekijk meer
Underneath the skin
What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?
Bekijk meer